FDA clears Abbott glucose-monitoring tool

The FDA has granted Abbott Laboratories approval to market its FreeStyle Navigator system, designed to continuously monitor the blood-sugar levels of diabetics. The device, which was cleared by European regulators last June, will be available in the second quarter of 2008 by prescription.

View Full Article in:

Chicago Sun-Times (free registration) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX